ASGE Recognized Industry Associate (ARIA) Training Program for Regeneron and Sanofi | August 2024-GITract In Disease

GITract In Disease_Small Intestine.update

Pdf Summary

The document discusses gastrointestinal tract diseases with a focus on the small intestine, covering topics like celiac disease, obscure gastrointestinal bleeding, small bowel obstruction, and mesenteric ischemia. Celiac disease is described as an autoimmune disorder triggered by gluten consumption, leading to small intestine damage. Symptoms of celiac disease include abdominal pain, malabsorption, and weight loss. Diagnosis involves serologic testing and upper endoscopy. Treatment involves strict gluten avoidance. Obscure gastrointestinal bleeding, arising without an obvious cause, is explored, with causes such as tumors and angiodysplasia discussed. Evaluation includes capsule endoscopy and device-assisted enteroscopy. Small bowel obstruction, a blockage preventing normal digestion, presents symptoms like abdominal pain and constipation. Causes include adhesions, hernias, and tumors, with diagnosis through imaging like x-rays and CT scans. Mesenteric ischemia, characterized by inadequate blood supply causing inflammation, can be acute or chronic and requires imaging for diagnosis and treatments such as angiography or surgery. Device-assisted enteroscopy techniques, including double balloon and rotational enteroscopy, are mentioned for evaluating obscure gastrointestinal bleeding. The document outlines essential information for internal educational purposes within Sanofi, emphasizing confidentiality and compliance with regulatory guidelines when discussing medical conditions and treatments with customers.

Keywords

gastrointestinal tract diseases

small intestine

celiac disease

obscure gastrointestinal bleeding

small bowel obstruction

mesenteric ischemia

autoimmune disorder

gluten consumption

capsule endoscopy

device-assisted enteroscopy